Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Feb-24 5:05 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 12-Feb-24 | Private Sale | 1,148 | $67.77 | $77,796.40 | (1%) 93.6K to 92.45K | |
| 31-Jan-24 4:36 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 29-Jan-24 | Private Sale | 906 | $64.14 | $58,109.20 | (< 1%) 94.51K to 93.6K | |
| 23-Jan-24 6:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Jan-24 | Private Sale | 3,413 | $65.00 | $221,831.00 | (3%) 97.92K to 94.51K | |
| 17-Jan-24 4:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Grant | 23,748 | -- | -- | 31% 76.41K to 100.16K | |
| 17-Jan-24 4:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Sale | 2,235 | $66.81 | $149,317.00 | (2%) 100.16K to 97.92K | |
| 05-Dec-23 7:29 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Dec-23 | Option Exercise | 110,000 | $15.09 | $1,659,900.00 | 144% 76.41K to 186.41K | |
| 05-Dec-23 7:29 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Dec-23 | Planned Option Sale | 110,000 | $60.81 | $6,689,300.00 | (59%) 186.41K to 76.41K | |
| 04-May-23 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-May-23 | Option Exercise | 5,000 | $15.09 | $75,450.00 | 7% 76.0K to 81.0K | |
| 04-May-23 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-May-23 | Planned Option Sale | 5,000 | $82.71 | $413,550.00 | (6%) 81.0K to 76.0K | |
| 05-Apr-23 4:50 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Apr-23 | Option Exercise | 5,000 | $15.09 | $75,450.00 | 7% 76.0K to 81.0K | |
| 05-Apr-23 4:50 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Apr-23 | Planned Option Sale | 5,000 | $74.05 | $370,250.00 | (6%) 81.0K to 76.0K | |
| 07-Mar-23 4:53 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Mar-23 | Option Exercise | 5,000 | $15.09 | $75,450.00 | 7% 76.0K to 81.0K | |
| 07-Mar-23 4:53 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Mar-23 | Planned Option Sale | 5,000 | $63.84 | $319,200.00 | (6%) 81.0K to 76.0K | |
| 22-Feb-23 6:36 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Grant | 9,886 | -- | -- | 15% 67.15K to 77.04K | |
| 22-Feb-23 6:36 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Payment of Exercise | 1,041 | $58.50 | $60,898.50 | (1%) 77.04K to 76.0K | |
| 14-Feb-23 5:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-23 | Payment of Exercise | 782 | $51.21 | $40,046.20 | (1%) 67.93K to 67.15K | |
| 06-Feb-23 5:35 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Feb-23 | Option Exercise | 5,000 | $15.09 | $75,450.00 | 7% 67.93K to 72.93K | |
| 06-Feb-23 5:35 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Feb-23 | Planned Option Sale | 5,000 | $55.85 | $279,250.00 | (7%) 72.93K to 67.93K | |
| 30-Jan-23 5:07 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-23 | Payment of Exercise | 551 | $52.77 | $29,076.30 | (< 1%) 68.48K to 67.93K | |
| 24-Jan-23 5:32 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jan-23 | Payment of Exercise | 1,912 | $52.05 | $99,519.60 | (3%) 70.39K to 68.48K | |
| 17-Jan-23 7:44 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Jan-23 | Grant | 27,488 | -- | -- | 64% 42.91K to 70.39K | |
| 05-Jan-23 10:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Jan-23 | Option Exercise | 5,000 | $15.09 | $75,450.00 | 12% 42.91K to 47.91K | |
| 05-Jan-23 10:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Jan-23 | Planned Option Sale | 5,000 | $50.70 | $253,500.00 | (10%) 47.91K to 42.91K | |
| 07-Dec-22 8:30 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 05-Dec-22 | Option Exercise | 5,000 | $15.09 | $75,450.00 | (9%) 52.91K to 47.91K | |
| 07-Dec-22 8:30 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 05-Dec-22 | Sale (Planned) | 5,000 | $50.38 | $251,900.00 | (10%) 47.91K to 42.91K | |
| 07-Nov-22 4:19 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Nov-22 | Option Exercise | 5,000 | $15.09 | $75,450.00 | (9%) 52.91K to 47.91K | |
| 07-Nov-22 4:19 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Nov-22 | Sale (Planned) | 5,000 | $58.54 | $292,700.00 | (10%) 47.91K to 42.91K | |
| 05-Oct-22 5:12 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Oct-22 | Option Exercise | 5,000 | $15.09 | $75,450.00 | 12% 42.91K to 47.91K | |
| 05-Oct-22 5:12 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Oct-22 | Planned Option Sale | 5,000 | $66.69 | $333,450.00 | (10%) 47.91K to 42.91K | |
| 07-Sep-22 4:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 06-Sep-22 | Option Exercise | 5,000 | $15.09 | $75,450.00 | 12% 42.91K to 47.91K | |
| 07-Sep-22 4:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 06-Sep-22 | Planned Option Sale | 5,000 | $60.38 | $301,900.00 | (10%) 47.91K to 42.91K | |
| 16-Aug-22 5:04 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Aug-22 | Option Exercise | 12,500 | $15.09 | $188,625.00 | 29% 42.91K to 55.41K | |
| 16-Aug-22 5:04 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Aug-22 | Planned Option Sale | 12,500 | $69.00 | $862,500.00 | (23%) 55.41K to 42.91K | |
| 12-Aug-22 5:01 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 11-Aug-22 | Option Exercise | 12,500 | $15.09 | $188,625.00 | 29% 42.91K to 55.41K | |
| 12-Aug-22 5:01 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 11-Aug-22 | Planned Option Sale | 12,500 | $67.00 | $837,500.00 | (23%) 55.41K to 42.91K | |
| 09-Aug-22 5:22 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Aug-22 | Option Exercise | 12,500 | $15.09 | $188,625.00 | 29% 42.91K to 55.41K | |
| 09-Aug-22 5:22 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Aug-22 | Planned Option Sale | 12,500 | $65.00 | $812,500.00 | (23%) 55.41K to 42.91K | |
| 04-Aug-22 6:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Aug-22 | Option Exercise | 5,000 | $15.09 | $75,450.00 | 12% 42.91K to 47.91K | |
| 04-Aug-22 6:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Aug-22 | Planned Option Sale | 5,000 | $56.43 | $282,150.00 | (10%) 47.91K to 42.91K | |
| 12-Jul-22 5:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 11-Jul-22 | Option Exercise | 5,000 | $15.09 | $75,450.00 | 12% 42.91K to 47.91K | |
| 12-Jul-22 5:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 11-Jul-22 | Planned Option Sale | 5,000 | $48.42 | $242,100.00 | (10%) 47.91K to 42.91K | |
| 12-Jul-22 5:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Apr-22 | Disposition (other) | 1,875 | -- | -- | (4%) 44.01K to 42.14K | |
| 14-Feb-22 4:34 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-22 | Payment of Exercise | 895 | $47.12 | $42,172.40 | (2%) 44.91K to 44.01K | |
| 01-Feb-22 6:01 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-22 | Payment of Exercise | 800 | $38.59 | $30,872.00 | (2%) 45.71K to 44.91K | (15%) |
| 25-Jan-22 4:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jan-22 | Grant | 26,051 | -- | -- | 133% 19.66K to 45.71K | |
| 11-Feb-21 4:10 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-21 | Payment of Exercise | 688 | $47.72 | $32,831.40 | (4%) 19.55K to 18.86K | (19%) |
| 01-Feb-21 4:44 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-21 | Grant | 9,375 | -- | -- | 92% 10.18K to 19.55K | |
| 12-Feb-20 5:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-20 | Grant | 9,375 | -- | -- | 100% 0 to 9.38K |